Area of research
Cellular and Molecular Neuroscience · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Nicotine and Norepinephrine transporter, with related work in Schizophrenia (object-oriented programming), Abstinence, Serotonin transporter. Notable publications include 'The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction', 'Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD', and 'Computerized cognitive remediation training for schizophrenia: An open label, multi-site, multinational methodology study'.
Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction
Computerized cognitive remediation training for schizophrenia: An open label, multi-site, multinational methodology study